SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-006097
Filing Date
2024-04-29
Accepted
2024-04-29 16:01:45
Documents
8
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240611xdef14a.htm DEF 14A 1315880
2 GRAPHIC tmb-20240611xdef14a_a001.jpg GRAPHIC 9601
3 GRAPHIC tmb-20240611xdef14a_a002.jpg GRAPHIC 5032
4 GRAPHIC tmb-20240611xdef14a_a003.jpg GRAPHIC 10983
5 GRAPHIC tmb-20240611xdef14a_a008.jpg GRAPHIC 56703
6 GRAPHIC tmb-20240611xdef14a_a009.jpg GRAPHIC 49124
7 GRAPHIC tmb-20240611xdef14a_bg001.jpg GRAPHIC 169866
8 GRAPHIC tmb-20240611xdef14a_bg002.jpg GRAPHIC 116560
  Complete submission text file 0001558370-24-006097.txt   1893568
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38150 | Film No.: 24890477
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)